Transactions

June 3, 2014
Corbus Pharmaceuticals Holdings, Inc

Corbus Pharmaceuticals Holdings, Inc

$10.3 Million

Private Placement
May 14, 2014
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

$28.8 Million

Secondary/Follow-On Sole Book-Runner
May 6, 2014
InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp.

$16.1 Million

Secondary/Follow-On Sole Book-Runner
May 1, 2014

San Luis Facility Development Corporation

$26.1 Million

New Issue
May 1, 2014
Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

$12 Million

IPO Sole Book-Runner
April 3, 2014
Intellicheck Mobilisa, Inc.

Intellicheck Mobilisa, Inc.

$2.1 Million

Secondary/Follow-On Sole Book-Runner
March 31, 2014
1347 Property Insurance Holdings, Inc.

1347 Property Insurance Holdings, Inc.

$17.4 Million

IPO Sole Book-Runner
March 26, 2014
Advaxis, Inc.

Advaxis, Inc.

$14.1 Million

Secondary/Follow-On Sole Book-Runner
March 6, 2014
Recro Pharma, Inc.

Recro Pharma, Inc.

$34.5 Million

IPO Sole Book-Runner
March 4, 2014
Ceres, Inc.

Ceres, Inc.

$23 Million

Secondary/Follow-On Sole Book-Runner
February 20, 2014
Semler Scientific, Inc.

Semler Scientific, Inc.

$10 Million

IPO Sole Book-Runner
February 13, 2014
GlobeImmune, Inc.

GlobeImmune, Inc.

$7.5 Million

Private Placement
February 10, 2014
NephroGenex, Inc.

NephroGenex, Inc.

$37.2 Million

IPO Sole Book-Runner
February 6, 2014
BioBlast Pharma Ltd.

BioBlast Pharma Ltd.

$4.8 Million

Private Placement
February 4, 2014
Biocept, Inc.

Biocept, Inc.

$19 Million

IPO Joint Book-Runner
January 30, 2014
CytRx Corporation

CytRx Corporation

$86.3 Million

Secondary/Follow-On

Note: Transactions occurring before April 1, 2018 executed prior to joining ThinkEquity, a Division of Fordham Financial Management., Inc.